Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01058538
What this trial is testing

A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumours
Philogen S.p.A. 33
Testing effectiveness (Phase 2)Study completedNCT02639182
What this trial is testing

AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Astellas Pharma Global Development, Inc. 133
Testing effectiveness (Phase 2)UnknownNCT01041482
What this trial is testing

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Chinese Academy of Medical Sciences 140
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT02809404
What this trial is testing

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

Who this might be right for
Breast CancerRenal Cell Carcinoma
Radboud University Medical Center 75
Not applicableActive Not RecruitingNCT07697417
What this trial is testing

Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney NeoplasmsEndophytic Renal Tumor+2 more
Tianjin Medical University Second Hospital 406
Not applicableLooking for participantsNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05661955
What this trial is testing

Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaMelanoma+1 more
BeiGene 113
Large-scale testing (Phase 3)Study completedNCT02030717
What this trial is testing

Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma

Who this might be right for
Pre- and Postoperative AnalgesiaSpinal AnesthesiaRenal Cell Carcinoma
Umeå University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT01575548
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)UnknownNCT02398552
What this trial is testing

A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.

Who this might be right for
Metastatic Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643
What this trial is testing

Avelumab Program Rollover Study

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 205
Testing effectiveness (Phase 2)Study completedNCT01731158
What this trial is testing

Sequential Therapy in Metastatic Renal Cell Carinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Central European Society for Anticancer Drug Research 22
Not applicableLooking for participantsNCT03977571
What this trial is testing

Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial

Who this might be right for
Kidney CancerRenal Cell Carcinoma MetastaticSynchronous Neoplasm
Niels Fristrup 400
Early research (Phase 1)Not Yet RecruitingNCT07828249
What this trial is testing

Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Centre Leon Berard 26
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)WithdrawnNCT03323710
What this trial is testing

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00324740
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 14
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00096525
What this trial is testing

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Next Page